Report Detail

According to our (Global Info Research) latest study, the global Newborn Screening Testing market size was valued at US$ 1116 million in 2025 and is forecast to a readjusted size of US$ 1664 million by 2032 with a CAGR of 5.9% during review period.
Newborn Screening Testing refers to the laboratory analysis performed on samples collected from infants shortly after birth to detect serious conditions that may not be clinically apparent but require early intervention. It encompasses the use of biochemical, immunological, and molecular testing methods to identify markers of inherited or congenital disorders, generate actionable screening results, and trigger confirmatory diagnostics and clinical follow-up when abnormalities are detected.
The newborn screening testing market is characterized by its role as foundational diagnostic infrastructure within maternal and child healthcare systems, resulting in stable demand and limited sensitivity to economic cycles. Market structure is shaped by centralized purchasing, rigorous quality standards, and long technology adoption timelines, which favor established testing platforms and vendors with proven reliability and regulatory alignment. Competitive differentiation increasingly centers on analytical accuracy, workflow automation, and the ability to integrate testing outputs with digital reporting and follow-up systems, rather than on testing volume alone. As screening programs modernize, growth opportunities are concentrated in advanced testing methodologies, replacement cycles of legacy platforms, and incremental expansion of screening panels driven by clinical evidence and policy endorsement.
This report is a detailed and comprehensive analysis for global Newborn Screening Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Screening Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Screening Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Screening Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Screening Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Screening Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Screening Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Cordlife, BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Screening Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Genetic Sequencing
Hearing Screening
Pulse Oximetry
Others
Market segment by Screening Purpose
Core Condition Screening
Expanded Condition Screening
Market segment by Service Model
Public Health Program
Consumer
Others
Market segment by Application
Public Hospitals
Private Hospitals
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Cordlife
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Screening Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening Testing, with revenue, gross margin, and global market share of Newborn Screening Testing from 2021 to 2026.
Chapter 3, the Newborn Screening Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Screening Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening Testing.
Chapter 13, to describe Newborn Screening Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Newborn Screening Testing by Type
    • 1.3.1 Overview: Global Newborn Screening Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Newborn Screening Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Genetic Sequencing
    • 1.3.4 Hearing Screening
    • 1.3.5 Pulse Oximetry
    • 1.3.6 Others
  • 1.4 Classification of Newborn Screening Testing by Screening Purpose
    • 1.4.1 Overview: Global Newborn Screening Testing Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Newborn Screening Testing Consumption Value Market Share by Screening Purpose in 2025
    • 1.4.3 Core Condition Screening
    • 1.4.4 Expanded Condition Screening
  • 1.5 Classification of Newborn Screening Testing by Service Model
    • 1.5.1 Overview: Global Newborn Screening Testing Market Size by Service Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Newborn Screening Testing Consumption Value Market Share by Service Model in 2025
    • 1.5.3 Public Health Program
    • 1.5.4 Consumer
    • 1.5.5 Others
  • 1.6 Global Newborn Screening Testing Market by Application
    • 1.6.1 Overview: Global Newborn Screening Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Public Hospitals
    • 1.6.3 Private Hospitals
    • 1.6.4 Others
  • 1.7 Global Newborn Screening Testing Market Size & Forecast
  • 1.8 Global Newborn Screening Testing Market Size and Forecast by Region
    • 1.8.1 Global Newborn Screening Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Newborn Screening Testing Market Size by Region, (2021-2032)
    • 1.8.3 North America Newborn Screening Testing Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Newborn Screening Testing Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Newborn Screening Testing Market Size and Prospect (2021-2032)
    • 1.8.6 South America Newborn Screening Testing Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Newborn Screening Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Newborn Screening Testing Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Revvity
    • 2.2.1 Revvity Details
    • 2.2.2 Revvity Major Business
    • 2.2.3 Revvity Newborn Screening Testing Product and Solutions
    • 2.2.4 Revvity Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Revvity Recent Developments and Future Plans
  • 2.3 Quest Diagnostics
    • 2.3.1 Quest Diagnostics Details
    • 2.3.2 Quest Diagnostics Major Business
    • 2.3.3 Quest Diagnostics Newborn Screening Testing Product and Solutions
    • 2.3.4 Quest Diagnostics Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.4 MedGenome
    • 2.4.1 MedGenome Details
    • 2.4.2 MedGenome Major Business
    • 2.4.3 MedGenome Newborn Screening Testing Product and Solutions
    • 2.4.4 MedGenome Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MedGenome Recent Developments and Future Plans
  • 2.5 Mayo Clinic Laboratories
    • 2.5.1 Mayo Clinic Laboratories Details
    • 2.5.2 Mayo Clinic Laboratories Major Business
    • 2.5.3 Mayo Clinic Laboratories Newborn Screening Testing Product and Solutions
    • 2.5.4 Mayo Clinic Laboratories Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
  • 2.6 GeneDx
    • 2.6.1 GeneDx Details
    • 2.6.2 GeneDx Major Business
    • 2.6.3 GeneDx Newborn Screening Testing Product and Solutions
    • 2.6.4 GeneDx Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GeneDx Recent Developments and Future Plans
  • 2.7 PreventionGenetics
    • 2.7.1 PreventionGenetics Details
    • 2.7.2 PreventionGenetics Major Business
    • 2.7.3 PreventionGenetics Newborn Screening Testing Product and Solutions
    • 2.7.4 PreventionGenetics Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 PreventionGenetics Recent Developments and Future Plans
  • 2.8 SYNLAB
    • 2.8.1 SYNLAB Details
    • 2.8.2 SYNLAB Major Business
    • 2.8.3 SYNLAB Newborn Screening Testing Product and Solutions
    • 2.8.4 SYNLAB Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 SYNLAB Recent Developments and Future Plans
  • 2.9 Cordlife
    • 2.9.1 Cordlife Details
    • 2.9.2 Cordlife Major Business
    • 2.9.3 Cordlife Newborn Screening Testing Product and Solutions
    • 2.9.4 Cordlife Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cordlife Recent Developments and Future Plans
  • 2.10 BGI Genomics
    • 2.10.1 BGI Genomics Details
    • 2.10.2 BGI Genomics Major Business
    • 2.10.3 BGI Genomics Newborn Screening Testing Product and Solutions
    • 2.10.4 BGI Genomics Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BGI Genomics Recent Developments and Future Plans
  • 2.11 Berry Genomics
    • 2.11.1 Berry Genomics Details
    • 2.11.2 Berry Genomics Major Business
    • 2.11.3 Berry Genomics Newborn Screening Testing Product and Solutions
    • 2.11.4 Berry Genomics Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Berry Genomics Recent Developments and Future Plans
  • 2.12 Annaroad
    • 2.12.1 Annaroad Details
    • 2.12.2 Annaroad Major Business
    • 2.12.3 Annaroad Newborn Screening Testing Product and Solutions
    • 2.12.4 Annaroad Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Annaroad Recent Developments and Future Plans
  • 2.13 Jiajian Medical Testing
    • 2.13.1 Jiajian Medical Testing Details
    • 2.13.2 Jiajian Medical Testing Major Business
    • 2.13.3 Jiajian Medical Testing Newborn Screening Testing Product and Solutions
    • 2.13.4 Jiajian Medical Testing Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jiajian Medical Testing Recent Developments and Future Plans
  • 2.14 Genesky
    • 2.14.1 Genesky Details
    • 2.14.2 Genesky Major Business
    • 2.14.3 Genesky Newborn Screening Testing Product and Solutions
    • 2.14.4 Genesky Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Genesky Recent Developments and Future Plans
  • 2.15 Weihansi Biomedical Technology
    • 2.15.1 Weihansi Biomedical Technology Details
    • 2.15.2 Weihansi Biomedical Technology Major Business
    • 2.15.3 Weihansi Biomedical Technology Newborn Screening Testing Product and Solutions
    • 2.15.4 Weihansi Biomedical Technology Newborn Screening Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Weihansi Biomedical Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Newborn Screening Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Newborn Screening Testing by Company Revenue
    • 3.2.2 Top 3 Newborn Screening Testing Players Market Share in 2025
    • 3.2.3 Top 6 Newborn Screening Testing Players Market Share in 2025
  • 3.3 Newborn Screening Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Newborn Screening Testing Market: Region Footprint
    • 3.3.2 Newborn Screening Testing Market: Company Product Type Footprint
    • 3.3.3 Newborn Screening Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Newborn Screening Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Newborn Screening Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Newborn Screening Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Newborn Screening Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Newborn Screening Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Newborn Screening Testing Market Size by Application (2021-2032)
  • 6.3 North America Newborn Screening Testing Market Size by Country
    • 6.3.1 North America Newborn Screening Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Newborn Screening Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Newborn Screening Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Newborn Screening Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Newborn Screening Testing Market Size by Country
    • 7.3.1 Europe Newborn Screening Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Newborn Screening Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Screening Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Newborn Screening Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Newborn Screening Testing Market Size by Region
    • 8.3.1 Asia-Pacific Newborn Screening Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Newborn Screening Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Newborn Screening Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Newborn Screening Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Newborn Screening Testing Market Size by Country
    • 9.3.1 South America Newborn Screening Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Newborn Screening Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Screening Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Newborn Screening Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Newborn Screening Testing Market Size by Country
    • 10.3.1 Middle East & Africa Newborn Screening Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Newborn Screening Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Newborn Screening Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Newborn Screening Testing Market Drivers
  • 11.2 Newborn Screening Testing Market Restraints
  • 11.3 Newborn Screening Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Newborn Screening Testing Industry Chain
  • 12.2 Newborn Screening Testing Upstream Analysis
  • 12.3 Newborn Screening Testing Midstream Analysis
  • 12.4 Newborn Screening Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Newborn Screening Testing. Industry analysis & Market Report on Newborn Screening Testing is a syndicated market report, published as Global Newborn Screening Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Newborn Screening Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report